We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations.
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced two additions to the senior management team of Astrea Bioseparations.